|4Feb 11, 9:46 PM ET

Broadway Fred 4

4 · BIOTELEMETRY, INC. · Filed Feb 11, 2021

Insider Transaction Report

Form 4
Period: 2021-02-09
Broadway Fred
SVP - Sales Marketing
Transactions
  • Disposition to Issuer

    Common Stock

    2021-02-09$72.00/sh29,375$2,115,0000 total
  • Disposition to Issuer

    Stock Options (Right to Buy)

    2021-02-09$63.32/sh12,058$763,5130 total
    Exercise: $8.68Exp: 2024-02-14Common Stock (12,058 underlying)
  • Disposition to Issuer

    Stock Options (Right to Buy)

    2021-02-09$61.64/sh15,558$958,9950 total
    Exercise: $10.36Exp: 2025-02-16Common Stock (15,558 underlying)
  • Disposition to Issuer

    Stock Options (Right to Buy)

    2021-02-09$62.43/sh15,158$946,3140 total
    Exercise: $9.57Exp: 2026-02-15Common Stock (15,158 underlying)
  • Disposition to Issuer

    Stock Options (Right to Buy)

    2021-02-09$47.35/sh6,003$284,2420 total
    Exercise: $24.65Exp: 2027-02-14Common Stock (6,003 underlying)
  • Disposition to Issuer

    Stock Options (Right to Buy)

    2021-02-09$38.65/sh8,653$334,4380 total
    Exercise: $33.35Exp: 2028-02-14Common Stock (8,653 underlying)
  • Disposition to Issuer

    Stock Options (Right to Buy)

    2021-02-09$18.78/sh9,369$175,9500 total
    Exercise: $53.22Exp: 2030-02-17Common Stock (9,369 underlying)
  • Disposition to Issuer

    Performance Stock Units

    2021-02-09$72.00/sh3,635$261,7200 total
    Exercise: $0.00Exp: 2021-02-14Common Stock (3,635 underlying)
  • Disposition to Issuer

    Performance Stock Units

    2021-02-09$72.00/sh1,987$143,0640 total
    Exercise: $0.00Exp: 2022-02-14Common Stock (1,987 underlying)
  • Disposition to Issuer

    Performance Stock Units

    2021-02-09$72.00/sh3,935$283,3200 total
    Exercise: $0.00Common Stock (3,935 underlying)
Footnotes (4)
  • [F1]Per the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock was validly tendered for $72.00 per share in cash (the "Offer Price"), less any applicable withholding taxes.
  • [F2]Includes 9,557 restricted stock units that, pursuant to the Merger Agreement, were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive the Offer Price, less any applicable withholding taxes.
  • [F3]Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes.
  • [F4]Per the terms of the Merger Agreement, each performance stock unit ("PSU") that was outstanding as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash equal to the product of (i) the total number of shares of Company common stock subject to such PSU that would have vested if the applicable performance period ended immediately prior to the Effective Time (assuming that any applicable performance conditions were deemed to be achieved at the target performance level), multiplied by (ii) the Offer Price, less applicable withholding taxes.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION